Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus
✍ Scribed by M. P. Arrazola; Dr. J. R. De Juanes; A. J. Aragón; A. Garcia de Codes; J. T. Ramos
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 326 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A study was conducted to investigate the immunogenicity of a recombinant DNA hepatitis B vaccine in neonates and children of HIV‐infected women. Immunization against hepatitis B consisted of three 10 μg doses of the vaccine administered on a 0‐, 1‐ and 6‐month schedule. The children were followed up for an average of 11 months. Of the 118 HIV‐positive neonates who participated in the study, 95 lost their HIV antibodies during the follow‐up period. Most (94.2%) of the latter who completed the study responded to the vaccine. Of the 23 who remained HIV‐positive, 17 completed the study and 7 produced hepatitis B antibodies. © 1995 Wiley‐Liss, inc.
📜 SIMILAR VOLUMES
## Abstract Hepatitis E virus (HEV) is a newly‐identified causative agent of acute and chronic hepatitis in severely immunocompromized patients. The present study sought to assess the prevalences of past, recent, on‐going, and chronic HEV infections in patients infected with human immunodeficiency
## Abstract Relatively little is known about the role of hepatitis B virus (HBV) genotype G (HBV/G) in patients co‐infected with human immunodeficiency virus (HIV) and HBV. This study examined the prevalence and association of HBV/G to liver fibrosis in co‐infected patients. HBV genotypes were dete
## Abstract A study was undertaken to determine the prevalence and risk factors for serological evidence of hepatitis C virus (HCV) infection in patients infected with the human immunodeficiency virus (HIV). Tests for anti‐HCV antibody were carried out by enzyme‐linked immunoassay (EIA) on 101 HIV‐